Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vitamin B12 uptake receptors are specialized cell surface proteins that facilitate the internalization of cobalamin (Vitamin B12) into human cells. This group primarily consists of the Transcobalamin receptor (CD320), which mediates the uptake of the transcobalamin-B12 complex in peripheral tissues, and the CUBAM complex (composed of Cubilin and Amnionless), which is responsible for the absorption of the intrinsic factor-B12 complex in the terminal ileum and its reabsorption in the kidney (PubMed, Wikipedia). These receptors are essential for maintaining cellular levels of Vitamin B12, a vital cofactor for enzymes involved in DNA synthesis, methylation, and mitochondrial function (NIH, Wikipedia). Because CD320 is significantly upregulated in many types of cancer to support rapid cell proliferation, it has become a promising target for the delivery of B12-conjugated chemotherapeutic agents (PubMed, NIH). Dysfunctions in these receptors, often due to genetic mutations or autoimmune processes, lead to severe clinical conditions such as megaloblastic anemia and neurological deterioration (NIH, Wikipedia). Targeted therapies utilizing these receptors aim to either restore B12 levels or exploit the high uptake capacity of tumor cells for selective drug delivery (ACS, PubMed). The CUBAM complex also plays a role in renal protein reabsorption, making it a multi-functional system beyond vitamin transport (PubMed). Research into these receptors continues to expand their potential as both diagnostic biomarkers and therapeutic gateways in oncology and metabolic medicine (PubMed).
Receptor-mediated endocytosis and targeted drug delivery via B12-conjugates.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vitamin B12 uptake receptors (CD320/CUBAM).